A carregar...
BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide and 30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer (mCRC) have a 5-year overall survival rate of <10%. V-raf murine sarcoma viral oncogene homolog B1 (BRAF) and V-Ki-ras2 Ki...
Na minha lista:
| Publicado no: | Gastroenterol Rep (Oxf) |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7333923/ https://ncbi.nlm.nih.gov/pubmed/32665851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/goaa022 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|